Rare diseases are usually caused by a single genetic defect. Nevertheless, the search for the cause and the assessment of the effects is highly complex and difficult. Jörg Menche, adjunct principal investigator at the CeMM ...
Nov 9, 2021
0
26
A new study published in JAMA Health Forum by a University of Alabama at Birmingham researcher and colleagues is highlighting the lack of longitudinal data to evaluate and improve outcomes for those suffering from sickle ...
Oct 29, 2021
0
6
DEAR MAYO CLINIC: For years, I have been hearing about the advantages of taking CBD products for sleep, pain and just about anything that ails you. I now see these products everywhere being sold over the counter in drug stores. ...
Oct 28, 2021
0
3
By combining computational and experimental approaches, University of Pittsburgh School of Medicine and Prairie View A&M University researchers identified cancer drugs that show promise for treating pulmonary hypertension, ...
Oct 20, 2021
0
22
Three new genetic variants that regulate gene expression in the arteries are connected to fibromuscular dysplasia, an arterial disease that can cause dangerous consequences for the heart and vessels, according to a new study.
Oct 15, 2021
0
61
A team of scientists in Montreal and Paris has succeeded in identifying the gene responsible for the development of a food-dependent form of Cushing's Syndrome, a rare disease affecting both adrenal glands.
Oct 14, 2021
0
10
A team of Mass Eye and Ear Scientists led by Albert Edge, Ph.D., working with research fellow Yushi Hayashi, MD, Ph.D., has identified the mechanism that can lead to deafness in the rare syndrome, Norrie disease. The researchers ...
Oct 5, 2021
0
71
Primary sclerosing cholangitis (PSC) is a rare, chronic inflammatory disease of the bile ducts and difficult to treat. Studies conducted by the Division of Gastroenterology and Hepatology at MedUni Wien under the guidance ...
Sep 28, 2021
0
16
French pharmaceutical giant Sanofi announced on Wednesday its second acquisition of a US firm in as many months, buying transplant drug company Kadmon for $1.9 billion (1.6 billion euros).
Sep 8, 2021
0
3
A team of scientists led by Erik Storkebaum of Radboud University's Donders Institute have deciphered the molecular mechanism underlying a form of Charcot-Marie-Tooth (CMT) peripheral neuropathy. This disease affects both ...
Sep 3, 2021
0
58
